Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Aurélien Sokal

5PUBLICATIONS

113CO-AUTHORS

Innate immunityRadiation therapyImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Sep 18, 2024

Preschool-age children maintain a distinct memory CD4<sup>+</sup> T cell and memory B cell response after SARS-CoV-2 infection.

Benoît Manfroi, Bui Thi Cuc, Aurélien Sokal

|Sep 11, 2024

Rocuronium-specific antibodies drive perioperative anaphylaxis but can also function as reversal agents in preclinical models.

Alice Dejoux, Qianqian Zhu, Christelle Ganneau

|Nov 07, 2022

Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination.

Aurélien Sokal, Paul Bastard, Pascal Chappert

|Nov 05, 2021

Primary immune thrombocytopenia in very elderly patients: particularities in presentation and management: results from the prospective CARMEN-France Registry.

Aurélien Sokal, Thomas de Nadaï, Julien Maquet

|Apr 15, 2021

Rituximab-resistant splenic memory B cells and newly engaged naive B cells fuel relapses in patients with immune thrombocytopenia.

Etienne Crickx, Pascal Chappert, Aurélien Sokal

Pageof 1

Frequent Collaborators

4 joint publications

Pascal Chappert

4 joint publications

Matthieu Mahévas

3 joint publications

Claude-Agnès Reynaud

3 joint publications

Jean-Claude Weill

2 joint publications

Imane Azzaoui

2 joint publications

Marc Michel

2 joint publications

Bertrand Godeau

1 joint publications

Etienne Crickx

1 joint publications

Guillaume Bonnard

1 joint publications

Geoffrey Rossi

Frequent Collaborators

4 joint publications

Pascal Chappert

4 joint publications

Matthieu Mahévas

3 joint publications

Claude-Agnès Reynaud

3 joint publications

Jean-Claude Weill

Top Related Videos

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle

Published on : Jul 11, 2015

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on : Sep 15, 2023

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy

Published on : Nov 01, 2011

See more related videos

Top Related Videos

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle

Published on : Jul 11, 2015

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on : Sep 15, 2023

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy

Published on : Nov 01, 2011

See more related videos